Product Description: ICCB280 is a potent inducer of C/EBPα. ICCB280 exhibits anti-leukemic properties including terminal differentiation, proliferation arrest, and apoptosis through activation of C/EBPα and affecting its downstream targets (such as C/EBPε, G-CSFR and c-Myc)[1][2].
Applications: Cancer-programmed cell death
Formula: C23H18N2O4
References: [1]Radomska HS, et, al. A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation. J Biomol Screen. 2015 Oct;20(9):1150-9./[2]Sridhar R, et, al. Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα. Molecules. 2018 Aug 3;23(8):1938.
CAS Number: 2041072-41-5
Molecular Weight: 386.40
Compound Purity: 99.43
Research Area: Cancer
Solubility: DMSO : 83.33 mg/mL (ultrasonic)
Target: Apoptosis